Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis

M Drolet, É Bénard, N Pérez, M Brisson, H Ali, MC Boily… - The Lancet, 2019 - thelancet.com
Background More than 10 years have elapsed since human papillomavirus (HPV) vaccination
was implemented. We did a systematic review and meta-analysis of the population-level …

Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis

M Drolet, É Bénard, MC Boily, H Ali… - The Lancet infectious …, 2015 - thelancet.com
Background Human papillomavirus (HPV) vaccination programmes were first implemented
in several countries worldwide in 2007. We did a systematic review and meta-analysis to …

[HTML][HTML] Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries

…, EA Burger, D Martin, DTN Nguyen, É Bénard… - The Lancet, 2020 - thelancet.com
Background WHO is developing a global strategy towards eliminating cervical cancer as a
public health problem, which proposes an elimination threshold of four cases per 100 000 …

[HTML][HTML] Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle …

…, G Gingras, EA Burger, D Martin, KT Simms, É Bénard… - The Lancet, 2020 - thelancet.com
Background The WHO Director-General has issued a call for action to eliminate cervical
cancer as a public health problem. To help inform global efforts, we modelled potential human …

[HTML][HTML] Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from …

M Brisson, É Bénard, M Drolet, JA Bogaards… - The Lancet Public …, 2016 - thelancet.com
Background Modelling studies have been widely used to inform human papillomavirus (HPV)
vaccination policy decisions; however, many models exist and it is not known whether they …

[HTML][HTML] Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources …

…, JF Laprise, D Martin, M Jit, É Bénard… - The Lancet Infectious …, 2021 - thelancet.com
Background Introduction of human papillomavirus (HPV) vaccination has been slow in low-income
and middle-income countries (LMICs) because of resource constraints and …

Effectiveness and cost-effectiveness of human papillomavirus vaccination through age 45 years in the United States

…, M Drolet, D Martin, É Bénard… - Annals of internal …, 2020 - acpjournals.org
Background: In the United States, the routine age for human papillomavirus (HPV) vaccination
is 11 to 12 years, with catch-up vaccination through age 26 years for women and 21 years …

[HTML][HTML] Potential population-level effectiveness of one-dose HPV vaccination in low-income and middle-income countries: a mathematical modelling analysis

É Bénard, M Drolet, JF Laprise, G Gingras… - The Lancet Public …, 2023 - thelancet.com
Background Given the accumulating evidence that one-dose vaccination could provide high
and sustained protection against human papillomavirus (HPV) infection and related …

[HTML][HTML] Model comparisons of the effectiveness and cost-effectiveness of vaccination: a systematic review of the literature

M Drolet, É Bénard, M Jit, R Hutubessy, M Brisson - Value in Health, 2018 - Elsevier
Objectives To describe all published articles that have conducted comparisons of model-based
effectiveness and cost-effectiveness results in the field of vaccination. Specific objectives …

The impact of human papillomavirus catch-up vaccination in Australia: implications for introduction of multiple age cohort vaccination and postvaccination data …

…, B Donovan, CK Fairley, H Ali, É Bénard… - The Journal of …, 2017 - academic.oup.com
We used transmission-dynamic modeling to estimate the added effectiveness of vaccinating
multiple cohorts of females (12–26 years) in Australia compared with the theoretical …